Switching to systemic therapy after locoregional treatment failure: Definition and best timing

In patients with unresectable hepatocellular carcinoma (HCC) without both macrovascular invasion and extrahepatic metastasis, the initial treatment choice recommended is transarterial chemoembolization (TACE). Before sorafenib came into wide use, TACE had been pointlessly carried out repeatedly. It...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Mol Hepatol
Autors principals: Ogasawara, Sadahisa, Ooka, Yoshihiko, Koroki, Keisuke, Maruta, Susumu, Kanzaki, Hiroaki, Kanayama, Kengo, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Saito, Tomoko, Kondo, Takayuki, Suzuki, Eiichiro, Nakamoto, Shingo, Tawada, Akinobu, Chiba, Tetsuhiro, Arai, Makoto, Kato, Jun, Kato, Naoya
Format: Artigo
Idioma:Inglês
Publicat: The Korean Association for the Study of the Liver 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160341/
https://ncbi.nlm.nih.gov/pubmed/31937081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2019.0021n
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars